CRISPR THERAPEUTICS AG (CRSP) — institutional ownership

549 funds reported holding CRISPR THERAPEUTICS AG in their latest 13F filings, worth $5.75B in total (CUSIP H17182108).

Largest holders

1. Banque Cantonale Vaudoise — $1.31B
2. ARK Investment Management LLC — $516M
3. BlackRock, Inc. (BLK) — $455M
4. Orbis Allan Gray Ltd — $297M
5. Capital World Investors — $259M
6. STATE STREET CORP (STT, STT-PG) — $236M
7. GSK plc (GSK, GLAXF) — $176M
8. GEODE CAPITAL MANAGEMENT, LLC — $137M
9. VANGUARD GROUP INC — $119M
10. T. Rowe Price Investment Management, Inc. — $112M

Famous investors holding it

• Cathie Wood portfolio (ARK Investment Management)
• Two Sigma portfolio (Two Sigma Investments)
• Ken Griffin portfolio (Citadel Advisors)
• D. E. Shaw portfolio (D. E. Shaw & Co.)
• Izzy Englander portfolio (Millennium Management)

Insider buying and selling at CRISPR THERAPEUTICS AG

Who owns the most CRSP stock?

The largest institutional holders in the latest 13F filings are Banque Cantonale Vaudoise ($1.31B), ARK Investment Management LLC ($516M), BlackRock, Inc. (BLK) ($455M).

How many funds own CRSP?

549 funds reported holding it, worth $5.75B in total.